Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hepatic detoxification describes the collective metabolic processes in the liver by which endogenous and exogenous substances—including drugs, toxins, metabolic waste, and hormones—are transformed for safe elimination from the body. This process primarily involves a series of enzymatic reactions categorized as Phase I (mainly oxidation by cytochrome P450 enzymes) and Phase II (conjugation with molecules like glutathione or glucuronic acid), resulting in more water-soluble metabolites excretable in urine or bile. Although these mechanisms generally neutralize harmful compounds, they can sometimes generate active or even more toxic metabolites, contributing to idiosyncratic drug responses and toxicity. The activity of hepatic detoxification pathways varies substantially between individuals due to genetic differences in enzyme expression and function.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hepatic detoxification.